MARKET

MDWD

MDWD

Mediwound
NASDAQ
17.79
+0.57
+3.31%
After Hours: 17.79 0 0.00% 16:10 02/06 EST
OPEN
17.36
PREV CLOSE
17.22
HIGH
17.90
LOW
17.36
VOLUME
100.92K
TURNOVER
--
52 WEEK HIGH
22.51
52 WEEK LOW
14.14
MARKET CAP
228.34M
P/E (TTM)
-9.3696
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MDWD last week (0126-0130)?
Weekly Report · 6d ago
Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Cipla Ltd (IN:CIPLA)
TipRanks · 01/28 09:01
Analysts’ Top Healthcare Picks: CVS Health (CVS), Revolution Medicines (RVMD)
TipRanks · 01/27 16:40
Mediwound (MDWD) Gets a Buy from Alliance Global Partners
TipRanks · 01/26 13:07
Weekly Report: what happened at MDWD last week (0119-0123)?
Weekly Report · 01/26 09:55
Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Mediwound (MDWD) and Semler Scientific (SMLR)
TipRanks · 01/21 14:20
MediWound Ltd. Shareholders to Vote on 300,000 Share Increase for 2024 Incentive Plan at Upcoming Meeting
Reuters · 01/20 21:56
Weekly Report: what happened at MDWD last week (0112-0116)?
Weekly Report · 01/19 09:59
More
About MDWD
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Webull offers Mediwound Ltd stock information, including NASDAQ: MDWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDWD stock methods without spending real money on the virtual paper trading platform.